TRLV stock
TRLV · Trulieve Cannabis Corp. Subordinate Voting Shares · NYSE
What is the latest news on TRLV stock?
TRLV fell 6.69% to $9.35 on Nov 19, 2026. No TRLV story in the last two days; the most recent is below.
New Hillsborough County location will host grand opening celebration Friday, November 20TALLAHASSEE, Fla., Nov. 16, 2026 /CNW/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Tampa, Florida. The dispensary will host a grand opening on Friday, November 20, featuring specials, discounts, and partner giveaways."We are proud to expand our presence in Hillsborough County, providing patients convenient access to the medical cannabis products they rely on," said Kim Rivers, Truli
All TRLV newsFinancial highlights
Full financials- Revenue, TTM
- $1.08B
- Revenue growth
- -9.1%
- Net income, TTM
- -$445.60M
- Net margin
- -41.2%
- Free cash flow, TTM
- $169.75M
- Cash
- $326.69M
For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.
Latest news
8 items- PRTrulieve to Open Medical Cannabis Dispensary in Tampa, FloridaNew Hillsborough County location will host grand opening celebration Friday, November 20TALLAHASSEE, Fla., Nov. 16, 2026 /CNW/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Tampa, Florida. The dispensary will host a grand opening on Friday, November 20, featuring specials, discounts, and partner giveaways."We are proud to expand our presence in Hillsborough County, providing patients convenient access to the medical cannabis products they rely on," said Kim Rivers, Truli
- PRTrulieve Announces Preliminary Addition to the Russell 2000® and 3000® IndicesTALLAHASSEE, Fla., Nov. 16, 2026 /CNW/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that the company is set to join to the Russell 2000® and 3000® Indices as part of the semi-annual Russell Indexes reconstitution, according to a preliminary list published by FTSE Russell on Friday, November 13, 2026. Final index membership is scheduled to become effective after the market close on Friday, Dec 11, 2026. "We are thrilled to join the Russell 2000® and 3000® Indices, following uplisting to the New York Stock Exchange and dom
- PRTrulieve Announces November 2026 Event ParticipationTALLAHASSEE, Fla., Nov. 11, 2026 /CNW/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced planned event participation in November. IgniteIt Cannabis Capital & Policy Summit, November 18, 2026: Chief Corporate Affairs and Strategy Officer Christine Hersey will participate in the panel discussion In the Wake of Uplisting: What It Takes to Unlock Institutional Capital.Information about our events, links to events where available, and slide presentations can be found at: https://investors.trulieve.com/eventsAbout TrulieveTrulieve
- PRTrulieve Expands Medical Cannabis Access through Riverside Pharmacy in Gainesville, GeorgiaNew Trulieve-branded kiosk offers qualified patients product access, education, and personalized guidanceTALLAHASSEE, Fla., Nov. 10, 2026 /CNW/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that its medical cannabis products are now available to qualified patients at Riverside Pharmacy in Gainesville, Georgia. Riverside Pharmacy, an independent community pharmacy that has served Gainesville for more than 70 years, will offer Trulieve products through a dedicated Trulieve-branded kiosk within the pharmacy. The kiosk will
- SECSEC Form 10-Q filed by Trulieve Cannabis Corp. Subordinate Voting Shares10-Q - Trulieve Cannabis Corp. (0001754195) (Filer)
- SECTrulieve Cannabis Corp. Subordinate Voting Shares filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Trulieve Cannabis Corp. (0001754195) (Filer)
- PRTrulieve Reports Third Quarter 2026 ResultsThird quarter revenue of $230 million, with 64% gross marginCash flow from operations of $183 million and free cash flow of $120 million* in first nine months of 2026Received final DEA registrations pursuant to final order rescheduling state licensed medical marijuana to Schedule III under the Controlled Substances ActTALLAHASSEE, Fla., Nov. 5, 2026 /CNW/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced its results for the quarter ended September 30, 2026. Results are reported in accordance with U.S. Generally Accepted Accounting Principles (GAAP), unless otherwise indicated. Numbers may
- PRTrulieve Receives DEA Registrations for State-Licensed Medical Marijuana OperationsTALLAHASSEE, Fla., Nov. 2, 2026 /CNW/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that Trulieve has received registrations for medical marijuana dispensaries as part of the initial registrations issued by the U.S. Drug Enforcement Administration (DEA). On Friday, the DEA announced it has begun the initial issuance of federal registrations to qualifying state licensed medical marijuana dispensaries, marking the first phase of the Attorney General's order in April that established a federal framework for qualifying medical marijuana businesses while maintaining federal controls under t
TRLV rankings
- Other4(50%)
- SEC Filings2(25%)
- Earnings1(13%)
- Leadership1(13%)
Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV) is a Medicinal Chemicals and Botanical Products company listed on NYSE. In the last 30 days Quantisnow tracked 8 wire items for TRLV, including 4 press releases and news items, 2 SEC filings and 1 earnings update. The most recent was published Nov 16, 2026.
TRLV FAQ
8 questionsWhat does Trulieve Cannabis Corp. Subordinate Voting Shares do?
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth.What is TRLV revenue?
Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV) reported $1.08B of revenue for the twelve months ended Sep 30, 2026. That is down 9.1% from the year before. Revenue for fiscal 2025 was $1.18B.Is TRLV profitable?
No. Trulieve Cannabis Corp. Subordinate Voting Shares reported a net loss of $445.60M for the twelve months ended Sep 30, 2026.How much cash and debt does TRLV have?
Trulieve Cannabis Corp. Subordinate Voting Shares reported $326.69M in cash and cash equivalents and $196.01M of debt on its most recent balance sheet in SEC filings.Where does TRLV stock trade?
Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV) is listed on NYSE.What sector and industry is TRLV in?
Trulieve Cannabis Corp. Subordinate Voting Shares operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What companies are similar to TRLV?
Notable peers in the same industry include RLX (RLX Technology Inc.), OBIO (Orchestra BioMed Holdings Inc.), DFTX (Definium Therapeutics Inc.), CRON (Cronos Group Inc.), BTI (British American Tobacco Industries p.l.c.). Compare TRLV side-by-side with any of them on Quantisnow.How can I track TRLV on Quantisnow?
Quantisnow aggregates Trulieve Cannabis Corp. Subordinate Voting Shares's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TRLV to receive live email and push alerts on every new disclosure.
Is something on this page wrong, or out of date? Request a change